Множествена склероза и Covid-19: интервю с акад. Иван Миланов

Covid - 19 pandemic is new challenge for the science and quite often there are more questions than answers. SmartMS supported by Тeva addressed your questions in an interview with Acad. Ivan Milanov. 0:00 Annotation of the topic by Dr. Michaela Sergeeva, neurologist. 1:30 How much at risk are MS patients in the present pandemic? 3:50 Are people over 65 or those on disease-modifying therapy at greater risk? 10:38 What is advisable for MS patients who have positive Covid test, or else if they have the clinical symptoms of Covid? 11:30 Are therapies, prescribed for the symptoms of Covid, considered as safe for the people with MS? 14:12 What are the risks of exacerbation of multiple sclerosis during a Covid infection? 15:02 If the patients can stay safe and unconcerned when visiting their consulting doctor at a hospital or a medical centre? 16:34 What is advisable for the patients who may get a relapse during the pandemic? Are there any additional risks? 19:05 What is advisable for patients with MS that have another medical complaint? Can they visit without concern another hospital or a rehabilitation centre? 19:40 Are there certain indications as to when patients with multiple sclerosis should be tested for Covid? 21:02 Vitamins or other immune-simulating agents. 21:40 Should MS patients get vaccinated? Are there any complications related to disease-modifying therapies? 23:25 Should there be some postponement of MS therapies after a vaccine is applied? 24:45 Should patients who went through Covid get vaccinated? 26:14 What are recommendations for newly diagnosed MS patients?